GCs exert an antagonistic effect on estrogen-dependent cell growth in ER+/GR+ breast carcinoma cells and reduce their cell proliferation through a functional crosstalk between both receptors (Figure 1B iv) (9, 32, 98–100). The gene discussed is NR3C1; the disease is breast carcinoma.